The committee consists of the seven Elected Officers of the Organization, the immediate Past Chair of the Organization, the Vice Chairs of each Section’s Governing Board, and At-Large Directors selected from the Full Board by the Chair and approved by the Board. The committee is authorized to exercise all powers of the Full Board, except for certain powers reserved for the Full Board under BIO’s Bylaws.
Staff Contact: Scott Whitaker
|
|
Chairman
Stephen A. Sherwin, MD
Chairman
Ceregene, Inc
|
Vice Chairman - ECS
Ron Cohen, MD
President & CEO
Acorda Therapeutics, Inc
|
Vice Chairman - Food & Ag
Barbara H. Wells, PhD
President & CEO
ArborGen, LLC
|
Vice Chairman - Healthcare
Tom Watkins
Human Genome Sciences, Inc
|
Treasurer
Mark Skaletsky
President & CEO
Fenway Pharmaceuticals, Inc
|
Secretary
Fabrizio Bonanni, Dr. Chem.
Executive Vice President, Operations
Amgen Inc
|
Member
Joshua Boger, PhD
Founder and CEO (retired)
Vertex Pharmaceuticals Incorporated
|
Member
Ian T. Clark
Head of Global Product Strategy & Chief Marketing Officer
Roche Pharma Division
|
Member
Douglas A. Doerfler
President & CEO
MaxCyte, Inc
|
Member
Paul J. Hastings
President & CEO
OncoMed Pharmaceuticals, Inc
|
Member
Rachel K. King, MBA
President & CEO
GlycoMimetics, Inc
|
Member
James C. Mullen
President & CEO
Biogen Idec, Inc
|
Member
Richard Pops
Chairman, President & CEO
Alkermes, Inc
|
Member
David E. I. Pyott
Chairman & CEO
Allergan, Inc
|
Member
Joachim Schneider
Head of BioScience
Bayer CropScience, Inc
|
Member
Alan Shaw, PhD
President & CEO
Codexis, Inc
|
Member
Henri A. Termeer
Chairman, President & CEO
Genzyme Corporation
|
Vice Chairman - I&E Section
Tjerk de Ruiter
Chief Executive Officer
Genencor® A Danisco Division
|
Printer Friendly